3-Year Outcomes From the Evolut Low Risk TAVR Bicuspid Study.
Zahr F, Ramlawi B, Reardon MJ, Deeb GM, Yakubov SJ, Song HK, Kleiman NS, Chetcuti SJ, Gada H, Mumtaz M, Leung S, Merhi W, Rovin JD, DeFrain M, Muppala M, Kauten J, Rajagopal V, Huang J, Ito S, Forrest JK.
Zahr F, et al. Among authors: song hk.
JACC Cardiovasc Interv. 2024 Jul 22;17(14):1667-1675. doi: 10.1016/j.jcin.2024.05.017.
JACC Cardiovasc Interv. 2024.
PMID: 39048253